September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
ASSOCIATION OF ADVANCED GLYCATION END PRODUCTS WITH OPEN ANGLE GLAUCOMA: THE ALIENOR STUDY.
Author Affiliations & Notes
  • Cedric Schweitzer
    OPHTHALMOLOGY, CHU BORDEAUX, BORDEAUX, France
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • Audrey Cougnard-Gregoire
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • VINCENT RIGALLEAU
    ENDOCRINOLOGY, CHU BORDEAUX, BORDEAUX, France
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • Marie-Noelle Delyfer
    OPHTHALMOLOGY, CHU BORDEAUX, BORDEAUX, France
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • Marie B Rougier
    OPHTHALMOLOGY, CHU BORDEAUX, BORDEAUX, France
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • Jean-François Dartigues
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • Jean-Francois Korobelnik
    OPHTHALMOLOGY, CHU BORDEAUX, BORDEAUX, France
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • Cecile DelCourt
    UNIV. BORDEAUX, INSERM, U1219-Bordeaux Population Health Center, BORDEAUX, France
  • Footnotes
    Commercial Relationships   Cedric Schweitzer, None; Audrey Cougnard-Gregoire, THEA (R); VINCENT RIGALLEAU, None; Marie-Noelle Delyfer, ALLERGAN (C), BAUSCH & LOMB (C), BAYER (C), NOVARTIS (C), THEA (C); Marie Rougier, ALLERGAN (C), BAUSCH & LOMB (C), BAYER (C), NOVARTIS (C), THEA (C); Jean-François Dartigues, None; Jean-Francois Korobelnik, ALCON (C), ALIMERA (C), ALLERGAN (C), BAUSCH & LOMB (C), BAYER (C), HORUS (C), NOVARTIS (C), THEA (C), ZEISS (C); Cecile DelCourt, ALLERGAN (C), BAUSCH & LOMB (C), NOVARTIS (C), THEA (C)
  • Footnotes
    Support  Laboratoires Théa, Fondation Voir et Entendre
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2612. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Cedric Schweitzer, Audrey Cougnard-Gregoire, VINCENT RIGALLEAU, Marie-Noelle Delyfer, Marie B Rougier, Jean-François Dartigues, Jean-Francois Korobelnik, Cecile DelCourt; ASSOCIATION OF ADVANCED GLYCATION END PRODUCTS WITH OPEN ANGLE GLAUCOMA: THE ALIENOR STUDY.. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2612.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : to analyze the association between open-angle glaucoma (OAG) and skin autofluorescence (sAF), which reflects tissue accumulation of advanced glycation end products (AGEs), in elderly subjects.

Methods : The ALIENOR (Antioxydants, Lipides Essentiels, Nutrition and maladies OculaiRes) Study is a population-based cohort study on age-related eye diseases performed in elderly residents of Bordeaux, aged 75 years and older. In 2009-2010, glaucoma diagnosis was made using retinophotography of the optic nerve head and ISGEO (international society for epidemiologic and geographical ophthalmology) criteria. sAF was measured with an autofluorescence reader (DiagnOpticsTechnologies B.V., Groningen, Netherlands) in 467 subjects and was divided in tertiles. In 1999-2000 and 2009-2010, fasting plasma glucose (FPG) was measured and diabetes was defined by self-reported diabetes or diabetic treatment or FPG ≥7 mmol/L. Associations between OAG and sAF or the glycemic status were estimated using generalized estimating equation logistic regressions adjusted for age, sex, family history of glaucoma and presence of ocular hypertension.

Results : The mean age was 82.3+/- 4.2 years, 459 subjects had complete data and 31 had a glaucoma diagnosis. The mean sAF was 2.8+/-0.7 arbitrary units (AU). In multivariate analysis, subjects with high tertile of sAF exhibited significantly higher risk for OAG (odds-ratio (OR): 3.32, 95% confidence interval (CI): 1.02;10.73). FPG measured 10 years before the eye examination was significantly associated with higher risk of OAG (OR: 1.25, 95%CI: 1.01;1.55) but not FPG measured at the same time as eye examination (OR: 1.26, 95%CI: 0.95;1.67), although ORs were similar . No significant associations were found between diabetes at the same time as eye examination and 10 years before with OAG (OR: 1.07, 95%CI: 0.41;2.79; OR: 1.50, 95%CI: 0.45;5.03, respectively).

Conclusions : Our study is the first to demonstrate an association between OAG and higher level of sAF, which may act as a long-term biomarker of metabolic memory. As AGEs have been associated with oxidative stress, inflammation and metabolic disorders as diabetes or cardiovascular diseases, our results suggest an accelerated aging process involved in the glaucomatous optic neuropathy.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×